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Abstract
Aim: Worldwide, cardiac arrest (CA) remains a major cause of death. Most post-CA patients are admitted to the intensive care unit (ICU). The aim of this
study is to describe mortality rates and possible changes in mortality rates in patients with CA admitted to the ICU in the Netherlands between 2010 and
2016.
Methods: In this study, we included all adult CA patients registered in the National Intensive Care Evaluation (NICE) registry who were admitted to ICUs
in the Netherlands between 2010 and 2016. The primary outcome was 1-year mortality which was analysed by Cox regression. The secondary
outcomes were ICU mortality and hospital mortality. Hospital mortality was analysed by binary logistic regression analysis. Patients were stratified by
whether they experienced in-hospital cardiac arrest (IHCA) or out-of-hospital cardiac arrest (OHCA). Finally, the outcome over calendar time was
assessed for both groups.
Results: We included 26,056 CA patients: 10,618 (40.8%) IHCA patients and 14,482 (55.6%) OHCA patients. The 1-year mortality rate was 57.5%:
59% for IHCA and 56.4% for OHCA, p < 0.01. This mortality rate remained stable between 2010 and 2016 for IHCA (p = 0.31) and declined for OHCA
patients (p = 0.01). The hospital mortality rate was 50.3%: 50.5% for IHCA and 50.2% for OHCA, p = 0.66. This mortality rate remained stable between
20102016 for IHCA (p = 0.21) and decreased for OHCA patients (p < 0.01). An additional analysis with calendar year as a continuous variable showed
a mortality decline of 1.56% per calendar year for 1-year mortality.
Conclusion: This nationwide registry cohort study reported a 57.5% 1-year mortality rate for CA patients admitted to the ICU between 2010 and 2016.
We reported a decline in 1-year mortality for OHCA patients in these years.
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Introduction
Sudden cardiac arrest (CA) remains a major cause of death worldwide
(World Health Organization, WHO). In Europe, approximately
375,000 adults suffer annually from CA.1,2 Mortality rates in patients
admitted to the hospital due to CA have been reported to be between
5861%.35 If these CA patients are admitted to the intensive care
unit (ICU), mortality rates vary between 5366 %.68 Of all surviving
CA patients 2575% have poor neurological outcomes and a large
portion suffers from long-term side effects,911 such as post-traumatic
stress disorder (PTSD),12,13 impaired quality of life,14 and lower
physical and mental functioning.15
Recent studies have examined characteristics that are associated
with the mortality of CA patients. More specifically, these studies
focused on differences in patient characteristics,16,17 the location of
the CA (in- or out-of-hospital),1820 and hospital characteristics.4,6
Generally, these studies provide data on all CA patients, including
patients who died before hospital admission. However, there is no
recent study showing a nationwide overview of CA patients admitted
to the ICU.
In the Netherlands, 4.6% of all patients admitted to the ICU have
CA as primary diagnosis.21 The outcomes of these patients are highly
interesting because they survived the first episode of CA (namely,
cardiopulmonary resuscitation). However, they are prone to haemo-
dynamic deterioration/instability, ischaemia/reperfusion injury, and
neurological damage. In addition, large-scale data on the outcomes in
this patient group are lacking. This information would be particularly
relevant given recent changes in guidelines and treatments, such as
targeted temperature management (TTM).22 Therefore, we analysed
a large national database to investigate the mortality rates in CA
patients (both IHCA and OHCA) admitted to ICUs in the Netherlands.
Methods
Patient data
In this study, we used patient data included in the National Intensive
Care Evaluation (NICE) registry.21 This is a national quality registry in
the Netherlands for ICU care, in which demographics, physiological
and diagnostic data, patient outcomes, and ICU characteristics are
registered. The data are prospectively collected with a primary focus
on monitoring the quality of care in the ICU. We retrospectively
analysed the data from approximately 85% of ICU departments in
2010 to 100% of ICU departments in 2016 in the Netherlands.21,23
We included all adult CA patients (18 years) who were admitted to
the participating ICUs from 2010 to 2016. This period was selected
because starting in 2010, we were able to determine 1-year mortality.21,23
The Scientific Board of the NICE Foundation (number 2018-01) and the
Medical Ethics Committee of the Erasmus MC, Rotterdam, the
Netherlands (number MEC-2018-1228) approved this study and the
need for informed consent was waived.
Characteristics and clinical outcomes
We included patient characteristics (i.e., sex, age, body mass index
(BMI), and history (e.g., renal insufficiency/dialysis, chronic obstructive
pulmonary disease (COPD)/chronic respiratory insufficiency, cardio-
vascular insufficiency, liver cirrhosis, (haematologic) malignancy, and
immunologic insufficiency)), admission characteristics (i.e., Acute
Physiology and Chronic Health Evaluation (APACHE IV) score,
estimated mortality rate and diagnoses within 24 h of ICU admission
(e.g., acute kidney injury (AKI), the use of mechanical ventilation,
infection, the administration of thrombolytic therapy, vasoactive
medication use, and academic/non-academic hospital), and clinical
outcomes (length of stay, ICU mortality, hospital mortality, and 1-year
mortality). Supplementary Material Table A shows the definitions of
these variables.
First, we included all patients (henceforth referred to as CA
patients) registered with an admission diagnosis of CA or cardiopul-
monary resuscitation (CPR). Next, we stratified the characteristics
and clinical outcomes for IHCA and OHCA patients. However, IHCA
and OHCA were not encoded in the NICE registry. Therefore, we
defined IHCA as an admission diagnosis of CA or CPR, with admission
origin within the hospital, excluding the emergency department (ED).
OHCA was defined as an admission diagnosis of CA or CPR, with an
admission origin in the ED or home. Hospital and 1-year mortality rates
were calculated, and hazard ratios (HRs) per year were assessed
relative to the year 2010. We determined the 1-year mortality by using
an administrative claims database that is linked to the NICE registry
(i.e., Vektis data).23,24
Statistical analysis
All characteristics and clinical outcomes were described as counts (%)
and medians (interquartile range, IQR), as appropriate. The data are
shown for the total sample and were stratified by IHCA and OHCA.
Patients with unknown locations of CA were excluded from the
stratified analyses. To test for differences between IHCA and OHCA
patients, we used Chi-square and Wilcoxon tests for categorical and
continuous variables, respectively.
The primary outcome was 1-year mortality. We examined the
mortality trend over time using a Cox proportional hazard model with
calendar years from 2010 to 2016 as an independent variable. For
each calendar year, a dummy variable was included. The variables we
included in each of the regression models are stated in the
Supplementary Material Appendix 1. We built these regression
models in two ways: (1) univariable analysis and (2) multivariable
analysis adjusting for demographic and clinical characteristics and
including a random intercept for hospital. This was done to take the
correlation between patients from the same hospital into account. To
check whether the selection of different hospitals across the calendar
years might have influenced the results, we performed a sensitivity
analysis restricted to hospitals that registered their patients in each
calendar year of the study period (20102016). We present the
hazard ratios (HR) and 95% Confidence Intervals (95% CI) of model
(2), as this was the best possible representation of all the available
data. The adjusted effect of calendar year as a categorical variable on
the hazard of death was tested by means of a post-estimation Wald
test with number of degrees of freedom equal to the number of
calendar years minus 1 (for the reference category = 2010). In this test,
calendar year was included as categorical variable without assuming
a linear trend. As an additional analysis, we performed Cox
proportional hazards regression, including calendar year as a
continuous variable for the different outcomes. These analyses
enabled us to estimate the average change in mortality rates per year
over time. All models were analysed for IHCA and OHCA separately.
IHCA and OHCA were not compared in these analyses because of the
non-registered characteristics relevant to CA.
R E S U S C I T A T I O N 1 4 7 ( 2 0 2 0 ) 8 8 9 4 89
Our secondary outcomes were ICU mortality and hospital
mortality. For ICU mortality, we only present a percentage to make
a rough comparison with hospital mortality. For hospital mortality, we
analysed the data using a binary logistic regression model and
presented the Odd Ratios (ORs) and 95% CIs. All analyses were
performed using R-studio. A p-value < 0.05 was considered statisti-
cally significant.
Results
Between 2010 and 2016, a total of 567,856 patients were included in
the NICE registry, and 26,056 (4.6%) of those patients were
admitted due to CA: 10,618 (40.8%) IHCA patients and 14,482
(55.6%) OHCA patients. Data from 956 (3.6%) patients were
excluded from the comparison of OHCA versus IHCA due to an
unknown location of the CA.
Descriptive statistics
Table 1 presents the patient characteristics of all CA patients and then
those of the patients stratified into the IHCA and OHCA groups. The
majority of the CA patients were male, with an average age of 67 years
at the time of the arrest. IHCA patients were older and had overall more
comorbidities than OHCA patients. Table 2 presents the admission
characteristics. The median APACHE IV estimated mortality proba-
bility was 0.75. The majority of patients had a Glasgow coma scale
(GCS) at admission of 5 (61.7%). At admission, 87.1% of the
patients were mechanically ventilated. Table 3 presents the clinical
outcomes. The median length of ICU stay was 64 h (IQR 21-134) and
the median hospital length of stay was 6 days (IQR 2-15).
Primary outcome: 1-year mortality
Within one year after ICU admission, 14,974 (57.5%) CA patients
died. This 1-year mortality was significantly higher in IHCA patients
(59.0%) versus OHCA patients (56.4%, p < 0.01). In Supplementary
Material Fig. A, we present the KaplanMeier curve for 1-year
mortality for IHCA and OHCA patients. Fig. 1 presents the analysis
of model (2), as described in the methods section, of 1-year mortality
for IHCA and OHCA patients separately. In IHCA patients no
significant differences over time were observed. In OHCA patients a
significant decrease in 1-year mortality between 2010 and 2016 was
observed (all p < 0.02). The sensitivity analyses restricting to
hospitals that recruited patients the full study period gave similar
results.
Secondary outcomes: ICU mortality, hospital mortality, and
additional analyses
Of the total sample, 11,681 (44.8%) CA patients died in the ICU. The
ICU mortality rates were slightly lower for IHCA than for OHCA
patients (44.2% versus 45.4%, respectively, p = 0.05). During their
hospital admission, 13,072 (50.3%) CA patients died. This hospital
mortality rate was comparable in IHCA and OHCA patients (50.5%
versus 50.2%, respectively, p = 0.66).
For hospital mortality, there was no significant trend in IHCA
patients over time (Wald test (df) 8.39 (6), p = 0.21). However, the
analysis for hospital mortality in OHCA patients with calendar year as a
categorised variable showed significant differences between the
calendar years Wald test (df) 22.78 (6), p < 0.01). Inspecting the Odds
Ratios we found a decreasing trend, as shown in Fig. 2.
Next, the results of the additional analysis with calendar year as a
continuous variable showed no significant trend in 1-year mortality
over time for IHCA patients (HR 0.99, 95% CI 0.98-1.00, p = 0.13).
Furthermore, it confirmed the observed decline in 1-year mortality
over time for OHCA patients (HR 0.98, 95% CI 0.97-1.00, p < 0.01).
This HR shows a reduction in 1-year mortality of 1.56% per year over
the study period.
As we found a decreasing trend in 1-year mortality for OHCA
patients, we decided to perform an additional Cox regression using left
truncation at the time of hospital discharge (i.e., only selecting the
hospital survivors), see Supplementary Material Fig. B. This shows
that a significant trend over time remains present (p < 0.01).
Discussion
This is the first large nationwide study on 1-year mortality rates of CA
patients admitted to the ICU, and it was performed in the Netherlands
between 2010 and 2016. The secondary outcomes we described were
ICU mortality and hospital mortality. Overall, we found reasonable
mortality rates and a significant decrease in 1-year mortality of OHCA
patients between 2010 and 2016.
Table 1 – Patient characteristics.
Total samplea IHCA OHCA p-value
Patients 20102016 26,056 10,618 14,482
Age (IQR) 67 (5776) 69 (5977) 66 (5575) <0.01
Gender, male (%) 17,320 (66.5) 6731 (63.4) 9967 (68.8) <0.01
BMI (IQR) 25.7 (23.428.7) 25.7 (23.428.9) 25.7 (23.428.4) 0.99
BMI missing (%) 711 (6.6) 985 (6.8)
History (N = 26,056)
Cardiovascular insufficiency (%) 2291 (8.8) 1160 (10.9) 1030 (7.1) <0.01
COPD /respiratory insufficiency (%) 4070 (15.6) 1894 (17.8) 2042 (14.1) <0.01
Renal insufficiency (%) 1802 (6.9) 976 (9.2) 765 (5.3) <0.01
Liver cirrhosis (%) 273 (1) 138 (1.3) 125 (0.9) 0.01
(Hematologic) malignancy (%) 1092 (4.2) 692 (6.5) 374 (2.6) <0.01
Immunodeficiency(%) 1316 (5.1) 779 (7.3) 500 (3.5) <0.01
a In 956 patients, it was unknown if the cardiac arrest occurred in- or outside the hospital; these patients were excluded from the analyses.
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Table 2 – Admission characteristics in CA patients admitted to the ICU between 20102016.
Total samplea IHCA OHCA p-value
APACHE IV estimated mortality rate (IQR) 0.75 (0.450.89) 0.71 (0.320.90) 0.77 (0.540.88) <0.01
Admission type <0.01
Medical 23,156 (88.9) 7968 (75) 14,291 (98.7)
Urgent surgical 1682 (6.5) 1517 (14.3) 122 (0.8)
Elective surgical 1103 (4.2) 1088 (10.2) 6 (<1)
Diagnosis on admission
GCS  5 (%) 16,066 (61.7) 5333 (50.2) 10,167 (70.2) <0.01
GCS 614 (%) 4057 (15.6) 1736 (16.3) 2148 (14.8)
GCS 15 (%) 5391 (20.7) 3327 (31.3) 1851 (12.8)
GCS missing (%) 222 (2.1) 316 (2.2)
Dysrhythmia (%) 13,343 (51.2) 5138 (48.4) 7676 (53) <0.01
Mechanical ventilation (%) 22,701 (87.1) 8696 (81.9) 13,189 (91.1) <0.01
CVA (%) 1053 (4.1) 455 (4.3) 558 (3.9) 0.10
Intracranial mass (%) 708 (2.7) 264 (2.5) 421 (2.9) 0.04
Gastro intestinal bleeding (%) 480 (1.8) 277 (2.6) 189 (1.3) <0.01
Diabetes (%) 4438 (17) 2045 (19.3) 2221 (15.3) <0.01
Diagnosis at 24 h of ICU admission
GCS  5 (%) 13,541 (52) 4615 (43.5) 8420 (58.1) <0.01
GCS 614 (%) 4198 (16.1) 1621 (15.3) 2407 (16.6)
GCS 15 (%) 7664 (29.4) 4095 (38.6) 3312 (22.9)
AKI (%) 4617 (17.7) 2263 (21.3) 2188 (15.1) <0.01
Mechanical ventilation (%) 23,666 (90.8) 9229 (86.9) 13,592 (93.9) <0.01
Infection (%) 2768 (10.6) 1641 (15.5) 1062 (7.3) <0.01
Vasoactive medication (%) 18,962 (72.8) 7640 (72) 10,652 (73.6) <0.01
Thrombolytic therapy (%) 1354 (5.2) 560 (5.3) 756 (5.2) 0.87
Academic hospital (%) 7956 (23.9) 3102 (22.2) 4656 (26.1) <0.01
a In 956 patients, it was unknown if the cardiac arrest occurred in- or outside the hospital; these patients were excluded from the analyses.
Table 3 – Clinical outcomes in CA patients admitted to the ICU between 20102016.
Total samplea IHCA OHCA p-value
Length of ICU stay in hours (IQR) 64.2 (21.4133.8) 52.1 (17.2135.2) 69 (26.4133.2) <0.01
Hospital length of stay in days (IQR) 5.9 (1.814.8) 6.1 (1.515.1) 5.9 (214.6) 0.27
ICU mortality (%) 11,681 (44.8) 4690 (44.2) 6579 (45.4) <0.05
Hospital mortality (%) 13,072 (50.3) 5346 (50.5) 7256 (50.2) 0.66
1-year mortality (%) 14,974 (57.5) 6263 (59.0) 8169 (56.4) <0.01
a In 956 patients, it was unknown if the cardiac arrest occurred in or outside the hospital; these patients were excluded from the analyses.
Fig. 1 – Multivariable Cox regression analysis of 1-year mortality for IHCA (p = 0.31) and OHCA (p = 0.01) over calendar
time.
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As a primary outcome, we reported a 1-year mortality rate of 57.5%
in the total cohort. This 1-year mortality rate was slightly higher in IHCA
patients than in OHCA patients. Though in a smaller sample, Engsig
et al.25 investigated long-term outcomes and showed comparable
1-year mortality rates, which were similar for IHCA and OHCA patients
(47% and 51%, respectively). We found a stable 1-year mortality rate
between 2010 and 2016 for IHCA patients. Remarkably, the 1-year
mortality of OHCA patients decreased in this time period, and this
decrease persisted after limiting the analysis to the hospital survivors
(see Supplementary Material Fig. C). This could point to a healthier
discharged CA patient population.
As a secondary outcome, we studied hospital mortality, which was
approximately 50% in the total cohort, as well as for both IHCA and
OHCA patients separately. In addition, we found that hospital mortality
was stable for IHCA patients between 2010 and 2016. For OHCA, we
found a decreasing trend in hospital mortality in this time period. These
mortality rates are in line with those in previous studies reporting
hospital mortality rates in CA patients.7,2628
In this study, we found a median APACHE IV estimated mortality
rate of 0.75, which is much higher than the observed hospital mortality
rate. Zimmerman et al.29 validated this APACHE IV score for CA
patients in the United States. However, Brinkman et al.30 showed poor
APACHE IV score performance in CA patients in the Netherlands. Our
study was performed with the same data registry as was the study by
Brinkman et al.30 Because the APACHE IV score is not validated for CA
patients in the Netherlands, this difference in expected and observed
mortality could be explained.
Given the limitations of a nationwide observational dataset, we
could not fully study the underlying cause for the reduction in mortality
among the OHCA patients. However, we would like to discuss
possible explanations for the differences in mortality rates between
IHCA and OHCA patients and the decline in 1-year and hospital
mortality of OHCA patients.
First, although we have corrected our analyses for relevant patient
characteristics, CA characteristics may have changed during the
study period. For example, in the Netherlands public awareness of CA
is increasing over time due to nationwide education.31 This could have
resulted in a higher percentage of bystander life support and
automated external defibrillator (AED) use. In turn this may have
resulted in a shorter time to the return of spontaneous circulation
(ROSC), which we were unable to examine in the present study.
Second, AED use may have contributed to the decrease in the
mortality rate in OHCA patients. Despite the promising results,
worldwide AED use is still quite limited compared to the
Netherlands.18,20,32,33 Blom et al.32 showed that in the Netherlands,
the use of AEDs and hospital survival both increased over time in the
period 20062012. In this same period, Ringh et al.34 reported an
increase in the number and use of publicAEDs and its effect on mortality
rates in Sweden. Taken together, in our opinion, the widespread use of
AEDs in the Netherlands probably contributed to the decrease in 1-year
mortality in OHCA patients found in our study.
Another possible explanation for the decrease in the mortality rate
in OHCA patients is the predominant use of targeted temperature
management (TTM), compared to its limited use in IHCA patients.
Mounting research has been performed on temperature management
in CA patients,8,22,27,28,3537 mostly these studies have been
performed in OHCA patients. As stated in the 2015 guidelines, since
2010, a temperature of 3234 C is recommended, which changed in
2015 to 36 C.22 Several studies showed different results in goal
temperatures for the TTM, but they all recommend using hypothermia
or normothermia and preventing hyperthermia.8,22,3537 However,
Engsig et al.25 showed no difference in IHCA and OHCA patients.
Wang et al.38 showed a benefit for TTM in IHCA patients, but TTM was
performed in only 3.2% of the patients. Chan et al.39 also showed a low
TTM rate in IHCA patients and they found no association between
TTM and survival or neurological outcomes. In the Netherlands, it is
difficult to pinpoint the exact date of the implementation of the TTM
guidelines, as shown by Pickkers et al,8 while at the same time many
hospitals started using TTM for OHCA patients during our study
period. Thus, this may have contributed to the differences in mortality
trends between 2010 and 2016 in IHCA and OHCA patients found in
our study. Taken together, TTM is used more often in OHCA patients
and has shown some promising results. However, TTM is not used as
often in IHCA patients, although this may actually be a promising
treatment strategy for these patients too.
Fourth, in the Netherlands, no studies have been conducted on
the effect of cardiac rehabilitation on the mortality rate specifically in
CA patients. However, some studies on the effect of cardiac
Fig. 2 – Binary logistic regression analysis of hospital mortality for IHCA (p = 0.21) and OHCA (p < 0.01) over calendar
time.
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rehabilitationon mortality in acute coronary syndrome and cardiac
surgery patients showed a lower mortality rate for those who received
cardiac rehabilitation compared to those who did not.40,41OHCA patients
are more likely to receive cardiac rehabilitation.10,42 For these patients, a
cardiaccausesuchascoronarydisease,wasmost likely thereasonfor the
CA. Given the decrease in 1-year mortality rates in our study, which
persistedafterselectingonlyhospitalsurvivors, it is likely that rehabilitation
therapy contributed to this lower 1-year mortality in OHCA patients. It may
clarify the difference between IHCA and OHCA outcomes.
Finally, during the last decade the treatment of coronary diseases
improved. Advances in coronary revascularization and adherence to
secondary prevention guidelines (including internal cardiac defibrillatory
therapy) may have contributed to an important improvement in mortality
rates in OHCA patients, while this is not the case in IHCA patients.
Future research may study the possible effects of pre-ICU
characteristics and in- and post-hospital treatments on short- and
long-term mortality rates of CA patients admitted to the ICU. Our linear
trend should be regarded as a crude average of various up- and
downward movements of the graph. In the restricted time frame of our
analysis, these movements are hard to interpret as coincidence or due
to specific causes. For this reason, no nonlinear trends were included
in the analysis. In case a study can be performed with more data
relevant to CA from a longer time period a more specific trend analysis
(e.g. non-linear trend) will be informative.
Limitations
As in every (retrospective) study, this research had several limitations.
First, as mentioned before, the NICE registry is aimed at quality of care
at the ICU and not all characteristics relevant to CA are registered. In
particular, we did not have access to the following characteristics:
witnessed/unwitnessed CA, CPR delay, time until ROSC, primary
cardiac rhythm, cardiac interventions, AED use, mechanical compres-
siondevice use andcauseofarrest.These characteristics are important
when studying the determinants of the outcome of CA. Therefore, in
future research, these characteristics must be taken into account.
Second, the NICE registry does not record whether the CA took
place in- or out-of-hospital. We had to determine this with the best
possible approximation. With this method, we expect that some of the
IHCA patients were misclassified as OHCA. Most of the patients
admitted at the ICU with admission-origin ED were OHCA patients;
however, some of them experienced CA while in the ED. We assume
that this issue has limited consequences for the results, but we cannot
exclude the possibility of some bias.
Third, in this study, we could only report mortality rates.
Unfortunately, there were no data available on neurological outcomes;
therefore, we were unable to report survival with good neurological
outcome.
Finally, in some hospitals in the Netherlands, post-CA patients are
admitted to the cardiac care unit instead of the ICU. We were unable to
estimate how many patients were in this group as this is not recorded
or these data were not available to the authors. As a consequence, this
could result in different numbers of patients in comparison to the CA
numbers reported in other studies.
Conclusion
This nationwide registry cohort study reported a 57.5% 1-year
mortality rate for CA patients admitted to the ICU between 2010 and
2016. We reported a decline in 1-year mortality for OHCA patients in
these years.
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